<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2019.99164</article-id><article-id pub-id-type="publisher-id">ACM-32048</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20190900000_90905234.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  NPHS1基因突变致儿童激素耐药型肾病综合征1例报道
  Case Report of Steroid-Resistant Nephrotic Syndrome Children Caused by Mutations in NPHS1
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>丹</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>林</surname><given-names>毅</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>柏</surname><given-names>翠</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>大海</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>秋业</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>青岛大学附属医院儿科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>08</month><year>2019</year></pub-date><volume>09</volume><issue>09</issue><fpage>1068</fpage><lpage>1072</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   本研究报道了1例激素耐药型肾病综合征(steroid-resistant nephrotic syndrome, SRNS)患儿，总结了患儿的症状、体征、主要辅助检查结果及治疗反应，并对其进行病理检查及肾脏相关致病基因检测。病理结果为局灶节段性肾小球硬化症，基因检测提示患儿NPHS1基因存在复合杂合突变(c.803G&gt;A、c.1339G&gt;A、c.1802G&gt;C)，其中c.1339&gt;A、c.1802G&gt;C为致病突变，c.803G&gt;A国内外未见报道。 This study reported a case of steroid-resistant nephrotic syndrome child, by summarizing the child symptoms, signs, auxiliary examination results and treatment response, through pathological examination and kidney related pathogenic gene detection. The pathological result is focal segmental glomerulosclerosis, and the gene test indicated the presence of complex heterozygous mutation of NPHS1 (c.803G&gt;A, c.1339G&gt;A, c.1802G&gt;C), c.1339G&gt;A and c.1802G&gt;C which are disease genes, and c.803G&gt;A has not been reported at home and abroad. 
  
 
</p></abstract><kwd-group><kwd>激素耐药型肾病综合征，基因突变，NPHS1，儿童, Steroid-Resistant Nephrotic Syndrome</kwd><kwd> Gene Mutation</kwd><kwd> NPHS1</kwd><kwd> Children</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>NPHS1基因突变致儿童激素耐药型肾病综合征1例报道<sup> </sup></title><p>李丹，林毅，柏翠，王大海，张秋业<sup>*</sup></p><p>青岛大学附属医院儿科，山东 青岛</p><p><img src="//html.hanspub.org/file/4-1571021x1_hanspub.png" /></p><p>收稿日期：2019年8月11日；录用日期：2019年8月25日；发布日期：2019年9月5日</p><disp-formula id="hanspub.32048-formula30"><graphic xlink:href="//html.hanspub.org/file/4-1571021x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>本研究报道了1例激素耐药型肾病综合征(steroid-resistant nephrotic syndrome, SRNS)患儿，总结了患儿的症状、体征、主要辅助检查结果及治疗反应，并对其进行病理检查及肾脏相关致病基因检测。病理结果为局灶节段性肾小球硬化症，基因检测提示患儿NPHS1基因存在复合杂合突变(c.803G&gt;A、c.1339G&gt;A、c.1802G&gt;C)，其中c.1339&gt;A、c.1802G&gt;C为致病突变，c.803G&gt;A国内外未见报道。</p><p>关键词 :激素耐药型肾病综合征，基因突变，NPHS1，儿童</p><disp-formula id="hanspub.32048-formula31"><graphic xlink:href="//html.hanspub.org/file/4-1571021x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2019 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/4-1571021x8_hanspub.png" /> <img src="//html.hanspub.org/file/4-1571021x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>遗传性肾病综合征(nephrotic syndrome, NS)由足细胞或基底膜相关分子基因突变所引起，多表现对激素耐药，属于SRNS范畴，且对免疫抑制剂治疗反应亦欠佳。Nephrin是足细胞裂孔隔膜(slit diaphragm, SD)结构的重要组成分子，于1998年首次发现。Nephrin由NPHS1基因编码，是SD的重要结构蛋白，同时，也参与足细胞内的分子信号传递 [<xref ref-type="bibr" rid="hanspub.32048-ref1">1</xref>] 。NPHS1突变可引起芬兰型先天性肾病综合征1型。青岛大学附属医院在2017年收治1例SRNS患儿，进行了相关致病基因检测，在NPHS1基因发现了3个复合杂合突变。本研究旨在说明对足量激素治疗4~8周后尿蛋白仍未转阴的肾病综合征患儿，需进一步行基因检测明确。</p></sec><sec id="s4"><title>2. 临床资料</title><p>患儿，女，6岁，因发现颜面部水肿2天，加重伴尿量减少半天于2017年入住青岛大学附属医院。入院查体：呼吸24次/分，心率105次/分，血压93/58 mmHg。面部及双眼睑水肿，双肺呼吸音清，未闻及干湿性啰音，心音有力，律齐，各瓣膜区未闻及杂音，腹软，无压痛及反跳痛，肝脾肋下未及，双下肢无浮肿。实验室检查：尿液分析：蛋白3+，白细胞2+，白细胞计数284.7/ul，潜血1+，红细胞−，肝功：白蛋白15.7 g/L，补体测定：补体C4 0.12 g/L，补体C3 0.76 g/L，血脂分析：总胆固醇6.85 mmol/L，低密度脂蛋白胆固醇3.24 mmol/L，肝炎全套、抗核抗体、ENA抗体谱、抗链球菌溶血素O测定未见明显异常，血常规 + CRP示白细胞计数11.73 &#215; 10<sup>9</sup>/L，中性粒细胞计数8.76 &#215; 10<sup>9</sup>/L，血红蛋白131 g/L，血小板计数383&#215;10<sup>9</sup>/L，CRP &lt; 0.50 mg/l，免疫球蛋白(血)、结核感染T细胞(T-SPOT)检测、尿培养未见明显异常，血凝常规：抗凝血酶III 40%，活化部分凝血活酶时间(APTT) 39.80sec，APTT比值1.59 R，调节性淋巴细胞亚群：自然杀伤细胞4.56%，活化B细胞+NK细胞15.28%，泌尿系统超声未见异常，心肌酶未见异常，肾功：尿酸490.9 umol/L，尿素14.64 mmol/L，电解质：碳酸氢盐20.0 mmol/L，钠132.9 mmol/L。初步诊断：肾病综合征(肾炎型)、泌尿道感染、肝功能异常。</p><p>入院后予抗感染、扩容、利尿及抗凝治疗，予泼尼松2 mg/(kg.d)治疗3周后尿蛋白未转阴。行肾脏穿刺，结果示FSGS，行肾脏相关致病基因检测，结果示：NPHS1基因有3个杂合突变，分别为：c.803G&gt;A、c.1339G&gt;A、c.1802G&gt;C，经家系验证分析，其父c.803G&gt;A位点杂合变异，其母c.1339G&gt;A、c.1802G&gt;C位点杂合变异，见图1。确诊诊断：肾病综合征伴局灶节段性肾小球硬化性肾小球肾炎。治疗上继续予泼尼2 mg/(kg.d)治疗5周，出院后定期复查尿常规尿蛋白仍未转阴，发病2个月后加用他克莫司治疗，效果不佳。发病16个月后出现肾功能不全。目前持续随访中。</p><p>图1. SRNS患儿及其父母的基因突变图</p></sec><sec id="s5"><title>3. 讨论</title><p>NS是儿童最常见的肾小球疾病。临床症状包括大量蛋白尿、低白蛋白血症、水肿和高脂血症。儿童NS根据对激素治疗的初始反应分为激素敏感性肾病综合征(steroid-sensitive nephrotic syndrome, SSNS)和SRNS。根据2009年中华医学会儿科分会肾脏病学组制定的《儿童常见肾脏病关于激素耐药型肾病综合征诊治指南》，儿童SRNS诊断标准为：泼尼松1.5~2.0 mg/(kg.d) (最大不超过60 mg)治疗4~8周，或相应剂量的其他类型的肾上腺皮质激素治疗4~8周，尿蛋白不能转阴 [<xref ref-type="bibr" rid="hanspub.32048-ref2">2</xref>] [<xref ref-type="bibr" rid="hanspub.32048-ref3">3</xref>] 。SRNS的确诊依据病史、典型临床表现和实验室检查等。本例患儿出现眼睑浮肿、蛋白尿、低蛋白血症、血脂升高，符合NS诊断，泼尼松2 mg/(kg.d)治疗8周尿蛋白未转阴，符合SRNS的诊断。</p><p>近十几年肾脏病遗传学研究表明，一部分SRNS是肾小球滤过屏障遗传性结构缺陷所致 [<xref ref-type="bibr" rid="hanspub.32048-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.32048-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.32048-ref6">6</xref>] 。肾小球滤过屏障由三层结构组成，自内而外分别为毛细血管内皮细胞、肾小球基底膜以及足细胞层 [<xref ref-type="bibr" rid="hanspub.32048-ref7">7</xref>] ，足细胞足突之间形成SD是阻止蛋白渗漏进入尿液的最后一道屏障 [<xref ref-type="bibr" rid="hanspub.32048-ref8">8</xref>] 。目前大约有50个基因突变导致了SRNS，它们可分别作用于SD、足细胞细胞骨架、肾小球基底膜及线粒体蛋白等，相关的编码蛋白构成相互作用的网络，其中NPHS1基因突变是引起SRNS的一个常见原因。NPHS1基因定位于人染色体19q13.1，基因全长26 kb，含有29个外显子，转录产物mRNA含有5024 bp核苷酸，其中第157~3726位核苷酸为编码区，编码蛋白为nephrin分子，nephrin含有1214个氨基酸，属于黏附分子免疫球蛋白超家族成员，特异性表达于足细胞。Nephrin的细胞外段相互呈拉链状交错连接，是足细胞裂孔隔膜分子筛的结构基础，nephrin与CD2AP等分子结合，参与足细胞内外信号传递，保持足细胞形态和功能的完整性。本例患儿NPHS1基因检测异常，考虑为遗传性肾病综合症。</p><p>NPHS1突变可分为缺失突变、插入突变、无义突变、错义突变、剪切体/位点突变和启动子突变等多种类型，本例患儿NPHS1基因有3个突变，分别位于两个等位基因，属复合杂合突变。3个突变分别为：c.803G&gt;A、c.1339G&gt;A、c.1802G&gt;C。经家系验证分析，c.803G&gt;A突变来源于父亲，c.1339G&gt;A、c.1802G&gt;C突变均来源于母亲。</p><p>从临床表型上看，患儿母亲无肾脏疾病；患儿父亲2016年诊断为肾病综合征，根据孟德尔遗传定律得出突变基因为隐性基因，患儿临床确诊为SRNS，同时遗传了父母各自突变的隐性基因，为复杂杂合突变，表现出肾病综合征的一系列症状及体征。c.1339G&gt;A导致第447号氨基酸由谷氨酸变异为赖氨酸，c1802G&gt;C导致第601号氨基酸由甘氨酸变异为丙氨酸，两者均为错义突变，均有致病性，其中c.1339G&gt;A已报道与芬兰型先天性肾病综合征(CNF)有关 [<xref ref-type="bibr" rid="hanspub.32048-ref9">9</xref>] ，c1802G&gt;C已报道与激素抵抗性肾病综合征有关 [<xref ref-type="bibr" rid="hanspub.32048-ref10">10</xref>] ，c.803G&gt;A突变后引起NPHS1基因异常未见报道。通过应用蛋白质功能预测软件Phast Cons、SIFT、PolyPhen2及Mutation Taster对单个碱基变异进行分析，c.803G&gt;A突变位于NPHS1 chr19-36340175第7外显子上，致氨基酸改变p.R268Q，该变异不具有多态性。c.1339G&gt;A、c.1802G&gt;C、c.803G&gt;A突变位点的转录本编号为NM_00 1009944。c.803G&gt;A突变来自患儿父亲，结合患儿临床表现，考虑该位点可能是FSGS相关的致病基因的新变异。从文献分析看，在高加索人群及非洲裔美国人群中所发现的FSGS致病性突变，均未在我国FSGS患者中得到很好重复，提示可能在我国FSGS患者存在不同的遗传变异，该基因位点突变有可能是中国汉族人群FSGS患者的致病基因变异。</p><p>本研究仅诊断单一病例进行讨论分析，不能代表SRNS患者的整体水平，且缺乏基础研究支持。结合国内外文献，目前尚无该新发突变位点的体外研究。下一步本课题组将进行大样本量的研究，并通过细胞、动物实验进行功能验证，明确该突变位点的生物学意义。</p><p>遗传性NS患儿对激素及免疫抑制剂均耐药，给予糖皮质激素或免疫抑制剂不但无效，还使患儿需承受药物的不良反应与副作用，故治疗的主要方向是减轻蛋白尿和保护肾功能，延缓疾病进展。单基因SRNS预示着一个非常不利的长期预后，约50%的患者将在诊断后的10年内的发展成ESKD，需要透析和肾移植 [<xref ref-type="bibr" rid="hanspub.32048-ref11">11</xref>] ，伴有NPHS1纯合或复合杂合突变的SRNS患者在肾移植中有较低的复发风险 [<xref ref-type="bibr" rid="hanspub.32048-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.32048-ref13">13</xref>] 。对SRNS患儿进行NPHS1基因突变分析不仅有助于临床医生对SRNS患儿明确病因诊断、指导治疗和判断预后，还有助于临床医生为NPHS1基因突变的高危家庭提供遗传咨询和产前诊断，一旦产前明确诊断即应终止妊娠。</p></sec><sec id="s6"><title>文章引用</title><p>李 丹,林 毅,柏 翠,王大海,张秋业. NPHS1基因突变致儿童激素耐药型肾病综合征1例报道Case Report of Steroid-Resistant Nephrotic Syndrome Children Caused by Mutations in NPHS1[J]. 临床医学进展, 2019, 09(09): 1068-1072. https://doi.org/10.12677/ACM.2019.99164</p></sec><sec id="s7"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.32048-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Wickelgren, I. (1999) First Components Found for Key Kidney Filter. Science, 286, 225-226.  
&lt;br&gt;https://doi.org/10.1126/science.286.5438.225</mixed-citation></ref><ref id="hanspub.32048-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">The Subspecialty Group of Nephrology, Society of Pediatrics, Chinese Medical Association (2009) Evidence-Based Guidelines on Diagnosis and Treatment of Childhood Common Renal Diseases (I) Evidence-Based Guidelines on Diagnosis and Treatment of Steroid-Sensitive, Relaps-ing/Steroid-Resistant Nephrotic Syndrome (for Trial Implementation). Chinese Journal of Pediatrics, 47, 167-169.</mixed-citation></ref><ref id="hanspub.32048-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Lombel, R.M., Gipson, D.S. and Hodson, E.M. (2013) Treatment of Steroid-Resistant Nephrotic Syn-drome: New Guidelines from KDIGO. Pediatric Nephrology, 28, 415-426. &lt;br&gt;https://doi.org/10.1007/s00467-012-2310-x</mixed-citation></ref><ref id="hanspub.32048-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Benoit, G., Machuca, E. and Antignac, C. (2010) Hereditary Nephrotic Syndrome: A Systematic Approach for Genetic Testing and a Review of Associated Podocyte. Pediatric Nephrology, 25, 1621-1632.  
&lt;br&gt;https://doi.org/10.1007/s00467-010-1495-0</mixed-citation></ref><ref id="hanspub.32048-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Gbadegesin, R., Lavin, P., Foreman, J. and Winn, M. (2011) Pathogenesis and Therapy of Focal Segmental Glomerulosclerosis: An Update. Pediatric Nephrology, 26, 1001-1015. &lt;br&gt;https://doi.org/10.1007/s00467-010-1692-x</mixed-citation></ref><ref id="hanspub.32048-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Löwik, M.M., Groenen, P.J., Levtchenko, E.N., et al. (2009) Molecular Genetic Analysis of Podocyte Genes in Focal Segmental Glomerulosclerosis: A Review. European Journal of Pediatrics, 168, 1291-1304.  
&lt;br&gt;https://doi.org/10.1007/s00431-009-1017-x</mixed-citation></ref><ref id="hanspub.32048-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Machuca, E., Benoit, G. and Antignac, C. (2009) Genetics of Nephrotic Syndrome: Connecting Molecular Genetics to Podocyte Physiology. Human Molecular Genetics, 18, R185-R194. &lt;br&gt;https://doi.org/10.1093/hmg/ddp328</mixed-citation></ref><ref id="hanspub.32048-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Pavenstädt, H., Kriz, W. and Kretzler, M. (2003) Cell Bi-ology of the Glomerular Podocyte. Physiological Reviews, 83, 253-307. &lt;br&gt;https://doi.org/10.1152/physrev.00020.2002</mixed-citation></ref><ref id="hanspub.32048-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Aya, K., Tanaka, H. and Seino, Y. (2000) Novel Mutation in the Nephrin Gene of a Japanese Patient with Congenital Nephrotic Syndrome of the Finnish Type. Kidney International, 57, 401-404.  
&lt;br&gt;https://doi.org/10.1046/j.1523-1755.2000.00859.x</mixed-citation></ref><ref id="hanspub.32048-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Sadowski, C.E., Lovric, S., Ashraf, S., et al. (2015) A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome. Journal of the American Society of Nephrology, 26, 1279-1289.  
&lt;br&gt;https://doi.org/10.1681/ASN.2014050489</mixed-citation></ref><ref id="hanspub.32048-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Trautmann, A., Schnaidt, S., Lipska-Zietkiewicz, B.S., Bodria, M., Ozaltin, F., Emma, F., Anarat, A., Melk, A., Azocar, M., Oh, J., Saeed, B., Gheisari, A., Caliskan, S., Gellermann, J., Higuita, L.M.S., Jankauskiene, A., Drozdz, D., Mir, S., Balat, A., Szczepanska, M., Paripovic, D., Zurowska, A., Bog-danovic, R., Yilmaz, A., Ranchin, B., Baskin, E., Erdogan, O., Remuzzi, G., Firszt-Adamczyk, A., Kuz-ma-Mroczkowska, E., Litwin, M., Murer, L., Tkaczyk, M., Jardim, H., Wasilewska, A., Printza, N., Fidan, K., Sim-kova, E., Borzecka, H., Staude, H., Hees, K., Schaefer, F. and PodoNet Consortium (2017) Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. Journal of the American Society of Nephrology, 28, 3055-3065. &lt;br&gt;https://doi.org/10.1681/ASN.2016101121</mixed-citation></ref><ref id="hanspub.32048-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Wada, T. and Nangaku, M. (2015) A Circulating Permeability Factor in Focal Segmental Glomerulosclerosis: The Hunt Continues. Clinical Kidney Journal, 8, 708-715. &lt;br&gt;https://doi.org/10.1093/ckj/sfv090</mixed-citation></ref><ref id="hanspub.32048-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Konigshausen, E. and Sellin, L. (2016) Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates. BioMed Research International, 2016, Article ID: 3765608.  
&lt;br&gt;https://doi.org/10.1155/2016/3765608</mixed-citation></ref></ref-list></back></article>